Tretinoin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00755 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid nodulosis | KG + DL |
| 2 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 3 | juvenile idiopathic arthritis | KG + DL |
| 4 | juvenile chronic polyarthritis | KG + DL |
| 5 | spondyloarthropathy, susceptibility to | KG + DL |
| 6 | juvenile arthritis due to defect in LACC1 | KG + DL |
| 7 | osteoarthritis | KG + DL |
| 8 | pseudoachondroplasia | KG + DL |
| 9 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 10 | Quinquaud’s folliculitis decalvans | KG + DL |
| 11 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 12 | osteoarthritis susceptibility | KG + DL |
| 13 | alopecia antibody deficiency | KG + DL |
| 14 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 15 | alopecia mucinosa | KG + DL |
| 16 | alopecia areata | KG + DL |
| 17 | telogen effluvium | KG + DL |
| 18 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 19 | myosclerosis | KG + DL |
| 20 | brachyolmia | KG + DL |
| 21 | WHIM syndrome | KG + DL |
| 22 | acute lymphoblastic/lymphocytic leukemia | KG + DL |
| 23 | chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | KG + DL |
| 24 | pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 25 | atrichia with papular lesions | KG + DL |
| 26 | arthropathy | KG + DL |
| 27 | zinc, elevated plasma | KG + DL |
| 28 | chondrocalcinosis | KG + DL |
| 29 | ankylosing spondylitis | KG + DL |
| 30 | avascular necrosis of femoral head, primary | KG + DL |
| 31 | spondyloarthropathy | KG + DL |
| 32 | rheumatoid vasculitis | KG + DL |
| 33 | hyaline fibromatosis syndrome | KG + DL |
| 34 | Stickler syndrome, type I, nonsyndromic ocular | KG + DL |
| 35 | heparin cofactor 2 deficiency | KG + DL |
| 36 | combined immunodeficiency due to moesin deficiency | KG + DL |
| 37 | spondyloepimetaphyseal dysplasia, Handigodu type | KG + DL |
| 38 | platyspondylic dysplasia, Torrance type | KG + DL |
| 39 | transient arthritis | KG + DL |
| 40 | spondylometaphyseal dysplasia, Schmidt type | KG + DL |
| 41 | vertebral disease | KG + DL |
| 42 | negative rheumatoid factor polyarthritis | KG + DL |
| 43 | hemophilic arthropathy | KG + DL |
| 44 | Czech dysplasia, metatarsal type | KG + DL |
| 45 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 46 | megaepiphyseal dwarfism | KG + DL |
| 47 | mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis | KG + DL |
| 48 | inflammatory spondylopathy | KG + DL |
| 49 | spondyloperipheral dysplasia-short ulna syndrome | KG + DL |
| 50 | discitis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.